1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 1: Clinical characteristics and neuropsychological testing
SLE (n = 6) Healthy Controls (n = 5) P Value
Age (mean) (yr) 38.0 ± 13.2 34.2 ± 10.5 .619
Race .292
    Caucasian 2 (33%) 0 
    Hispanic 0 2 (40%) 
    African American 3 (50%) 2 (40%) 
    Asian 1 (17%) 1 (20%) 
Smoking 1 1 .361
High serum DNRAb titer 3 (50%) 1 (20%) .545
ANAM testing^{^a} 
    Matching grids 25.8 ± 9.2 40.4 ± 10.8 .042
    Match to sample 16.4 ± 5.9 35.7 ± 15.1 .043
    Continuous processing 65.6 ± 5.5 88.7 ± 14.0 .018
Beck Depression Inventory 4 ± 4.3 1.8 ± 3.0 .362
State Trait Anxiety Inventory 27.4 ± 5.9 25 ± 6.9 .573
SLEDAI (mean) 2.3 ± 1.5 
SLICC DI (mean) 0.5 ± 0.8 
Disease duration (mean) (range, 1–33) (yr) 13.3 ± 11.1 
Medications 
    Prednisone 1 (17%) (5 mg QD) 
    Immunosuppression^{^b} 2 (33%) 
    Hydroxychloroquine 5 (83%) 
Note:—QD indicates once daily.
↵a Automated Neuropsychological Assessment Metric: throughput scores that represent efficiency as a function of accuracy and time.
↵b Both subjects were on mycophenolate mofetil; 1000 mg QD and 500 mg QD, respectively.